Poland· PL-100544673
Daybu
A other nervous system drugs product containing trofinetidum, registered in Poland by Acadia Pharmaceuticals (Netherlands) B.V.. The same ATC class is registered in 2 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Trofinetidum is registered in 2 of 19 countries.
Countries holding a registration under ATC N07XX (other nervous system drugs), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 2 of them publish a price we can compare per daily dose
Trofinetidum · ATC N07XX
2 / 19 countries
- Czechiaprice
- Polandprice
The record
At a glance
URPL (Poland)- Active substance
- Trofinetidum
- Manufacturer
- Acadia Pharmaceuticals (Netherlands) B.V.
- Country
- Poland (PL)
- ATC code
- N07XX
- ATC class
- Other nervous system drugs
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Trofinetidum in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesDaybueAcadia Pharmaceuticals Inc.
- BelgiumDaybu 200 mg/mlAcadia Pharmaceuticals (Netherlands)
- CzechiaDAYBUAcadia Pharmaceuticals (Netherlands) B.V., Amsterdam
- FinlandDaybuAcadia Pharmaceuticals (Netherlands) B.V.
- SwedenDaybu 200 mg/ml Oral lösningAcadia Pharmaceuticals (Netherlands) B.V.
- CanadaDAYBUEACADIA PHARMACEUTICALS INC.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/6b9be726-fa12-48c5-bcef-c029b4736762 GET /v1/drugs/6b9be726-fa12-48c5-bcef-c029b4736762?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór doustny",
"source": "urpl",
"strength": "200 mg/ml",
"packaging": "Rp ¦ EU/1/26/2045/001 ¦ 168350\n1 butelka 450 ml ¦ 1 miarka 30 ml ¦ 1 miarka 110 ml",
"substance": "Trofinetidum 200 mg/ml",
"common_name": "Trofinetidum",
"pl_product_id": "100544673",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about trofinetidum.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.